RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma

Episodes

What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma
8 Nov· Hematologic Oncology Update
Dr Gilles Salles from the Memorial Sloan Kettering Cancer Center in New York, New York, reviews current and novel EZH1/2 inhibitor-based treatment strategies for follicular lymphoma.
- Listen Listen again Continue Playing...
- Listen later Listen later
Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma
30 Oct· Hematologic Oncology Update
Dr Tycel Phillips from the City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Michael Wang from the University of Texas MD Anderson Cancer Center in Houston discuss the current role of Bruton tyrosine kinase inhibitors for the management of newly diagnosed and relapsed/refractory mantle cell lymphoma.
- Listen Listen again Continue Playing...
- Listen later Listen later
Missing episodes?

Click here to refresh the feed.
Practical Perspectives: Current Management of Chronic Myeloid Leukemia
24 Oct· Hematologic Oncology Update
Drs Bhavana (Tina) Bhatnagar, Amanda Blackmon, Jorge Cortes, Michael J Mauro and Neil P Shah discuss recent updates on clinical treatment strategies for chronic myeloid leukemia.
- Listen Listen again Continue Playing...
- Listen later Listen later
Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma
17 Oct· Hematologic Oncology Update
Dr Stephen Horwitz from Memorial Sloan Kettering Cancer Center in New York, New York, discusses management strategies for previously untreated and relapsed peripheral T-cell lymphomas.
- Listen Listen again Continue Playing...
- Listen later Listen later
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series
10 Oct· Hematologic Oncology Update
Dr Matthew S Davids from Dana-Farber Cancer Institute in Boston, Massachusetts, reviews current available data and ongoing investigational treatment approaches for chronic lymphocytic leukemia.
- Listen Listen again Continue Playing...
- Listen later Listen later
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
12 Aug· Hematologic Oncology Update
Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma.
- Listen Listen again Continue Playing...
- Listen later Listen later
RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
12 Jul· Hematologic Oncology Update
Dr Joshua Brody from the Tisch Cancer Institute at Mount Sinai in New York, New York, Dr Ian W Flinn from OneOncology in Nashville, Tennessee, and Dr Tycel Phillips from the City of Hope Comprehensive Cancer Center in Duarte, California, discuss recent updates on available and novel treatment strategies for various lymphomas.
- Listen Listen again Continue Playing...
- Listen later Listen later
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
2 Jul· Hematologic Oncology Update
Dr Aaron T Gerds from the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, discusses recent updates on available and novel treatment strategies for myelofibrosis.
- Listen Listen again Continue Playing...
- Listen later Listen later
Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences
29 May· Hematologic Oncology Update
Dr Andrew D Zelenetz from Memorial Sloan Kettering Cancer Center in New York City discusses recent updates on available and emerging treatment strategies for various lymphomas.
- Listen Listen again Continue Playing...
- Listen later Listen later
Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
28 May· Hematologic Oncology Update
Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
- Listen Listen again Continue Playing...
- Listen later Listen later
Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma
24 May· Hematologic Oncology Update
Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.
- Listen Listen again Continue Playing...
- Listen later Listen later
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
14 May· Hematologic Oncology Update
Drs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progress in diagnosing and treating acute myeloid leukemia over the past year, as well as practical considerations for patients with the disease.
- Listen Listen again Continue Playing...
- Listen later Listen later
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
2 May· Hematologic Oncology Update
Dr Ruben A Mesa from Wake Forest University School of Medicine in Winston-Salem, North Carolina, discusses recent updates on available and novel treatment strategies for myelofibrosis.
- Listen Listen again Continue Playing...
- Listen later Listen later
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
26 Apr· Hematologic Oncology Update
Dr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz summarize the biology of paroxysmal nocturnal hemoglobinuria, current treatment approaches, and practical considerations for patients with the disease.
- Listen Listen again Continue Playing...
- Listen later Listen later
Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
24 Apr· Hematologic Oncology Update
Dr Naveen Pemmaraju from The University of Texas MD Anderson Cancer Center in Houston discusses updated findings from ASH 2023 on management approaches for myelofibrosis and polycythemia vera.
- Listen Listen again Continue Playing...
- Listen later Listen later
Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
12 Apr· Hematologic Oncology Update
Dr Bita Fakhri from Stanford University in Stanford, California, discusses recent updates from ASH 2023 for the management of chronic lymphocytic leukemia and Richter’s syndrome.
- Listen Listen again Continue Playing...
- Listen later Listen later
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
27 Mar· Hematologic Oncology Update
Dr Andrew M Evens from the Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Sonali M Smith from the University of Chicago in Illinois discuss clinical decision-making with numerous treatment strategies for lymphoma.
- Listen Listen again Continue Playing...
- Listen later Listen later
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
8 Mar· Hematologic Oncology Update
Dr Stephen T Oh from Washington University School of Medicine in St Louis, Missouri, discusses current and emerging monitoring and management strategies for myelofibrosis.
- Listen Listen again Continue Playing...
- Listen later Listen later
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
27 Feb· Hematologic Oncology Update
Dr Lindsey Roeker from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Jeff Sharman of the US Oncology Network in Eugene, Oregon, discuss relevant datasets from 2023 on the management of chronic lymphocytic leukemia.
- Listen Listen again Continue Playing...
- Listen later Listen later
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
17 Jan· Hematologic Oncology Update
Dr Richard M Stone from Dana-Farber Cancer Institute in Boston discusses the optimal selection and sequencing of systemic therapies for patients with acute myeloid leukemia and myelodysplastic syndromes.
- Listen Listen again Continue Playing...
- Listen later Listen later
Show more

Episodes

What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma

Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma

Practical Perspectives: Current Management of Chronic Myeloid Leukemia

Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma

Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis

Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences

Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia

Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series

Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria

Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma

Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia

Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series